Navidea biopharmaceuticals announces settlement of platinum litigation; receipt of noncompliance notice from nyse american

Dublin, ohio--(business wire)--navidea biopharmaceuticals, inc. (nyse american: navb) (“navidea” or the “company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced settlement of the ongoing litigation with platinum-montaur life sciences llc (“platinum-montaur”), an affiliate of platinum management (ny) llc, platinum partners value arbitrage fund l.p., platinum partners capital opportunity fund, platinum partners liquid opportunit
NAVB Ratings Summary
NAVB Quant Ranking